Ampersand Biosciences awarded contract for Map Analysis by the CDC

Ampersand Biosciences was awarded a contract by the CDC Office of Acquisition Services (OAS) [HHS – CDC] on May 30, 2018 until November 30, 2018 for map analysis.

NAICS: 541714 – Research and Development in Biotechnology (except Nanobiotechnology)
PSC: B504 – Special Studies/Analysis – Chemical/Biological